Cytomegalovirus glycoprotein H genotype distribution and the relationship with hearing loss in children

Area of Science:

• Virology
• Genetics
• Pediatrics

Background:

• Congenital Cytomegalovirus (CMV) infection is a primary cause of infant hearing loss.
• The CMV envelope glycoprotein H (gH), encoded by ORF UL75, is crucial for viral entry and a key immune target.
• The relationship between CMV gH variants, viral load, and clinical outcomes in infected children requires further investigation.

Purpose of the Study:

• To analyze the genetic variation of the CMV UL75 gene (gH) in infants with congenital and postnatal CMV infections.
• To determine the association between gH genotypes, viral load, and the development of sequelae, particularly hearing loss.
• To assess if gH genotype predicts clinical outcomes in newborns with congenital CMV infection.

Main Methods:

• Genotyping of CMV UL75 gene from isolates of 42 congenitally infected newborns and 93 infants with postnatal or unproven congenital CMV.
• PCR amplification and analysis for UL75 genetic variation.
• Quantitative real-time PCR for measuring CMV viral load in urine.

Main Results:

• No significant difference in gH genotype distribution between congenital and postnatal CMV infections.
• Mixed-genotype infections (gH1 and gH2) detected in approximately 25% of patients.
• CMV gH1 genotype infection and high urine viral load were associated with sensorineural hearing loss.
• CMV gH2 genotype infection appeared to diminish the risk of hearing loss.

Conclusions:

• CMV gH genotype does not predict overall clinical sequelae in newborns with congenital CMV infection.
• The study suggests a potential association between specific CMV gH genotypes and the risk of hearing loss in children.
• Further research is warranted to elucidate the role of gH variants in CMV pathogenesis and long-term outcomes.